These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 9924317)
21. A restricted clonal T-cell receptor αβ repertoire in Sézary syndrome is indicative of superantigenic stimulation. van der Fits L; Sandberg Y; Darzentas N; Zoutman WH; Tielemans D; Wolvers-Tettero IL; Vermeer MH; Langerak AW Br J Dermatol; 2011 Jul; 165(1):78-84. PubMed ID: 21410672 [TBL] [Abstract][Full Text] [Related]
22. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings. Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144 [TBL] [Abstract][Full Text] [Related]
23. CD8+ Sézary syndrome with interleukin-22 production modulated by bacterial sepsis. Shimauchi T; Sasada K; Kito Y; Mori T; Hata M; Fujiyama T; Ito T; Hirakawa S; Tokura Y Br J Dermatol; 2013 Apr; 168(4):881-3. PubMed ID: 23013419 [No Abstract] [Full Text] [Related]
24. Rapid progression of immune dysregulation in an HIV-infected patient with Sézary syndrome. Dadoo AS; Steenkamp I Dermatol Online J; 2019 Jan; 25(1):. PubMed ID: 30710903 [TBL] [Abstract][Full Text] [Related]
26. Abatement of Sézary syndrome lesions following treatment with acyclovir. Scheman AJ; Steinberg I; Taddeini L Am J Med; 1986 Jun; 80(6):1199-202. PubMed ID: 2942033 [TBL] [Abstract][Full Text] [Related]
27. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients. Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734 [TBL] [Abstract][Full Text] [Related]
28. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas. Bosisio FM; Cerroni L Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852 [TBL] [Abstract][Full Text] [Related]
29. Histopathological and immunophenotypical criteria for the diagnosis of Sézary syndrome in differentiation from other erythrodermic skin diseases: a European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force Study of 97 cases. Klemke CD; Booken N; Weiss C; Nicolay JP; Goerdt S; Felcht M; Géraud C; Kempf W; Assaf C; Ortonne N; Battistella M; Bagot M; Knobler R; Quaglino P; Arheiliger B; Santucci M; Jansen P; Vermeer MH; Willemze R Br J Dermatol; 2015 Jul; 173(1):93-105. PubMed ID: 25864856 [TBL] [Abstract][Full Text] [Related]
30. Progressive outer retinal necrosis after bone marrow transplantation. Lewis JM; Nagae Y; Tano Y Am J Ophthalmol; 1996 Dec; 122(6):892-5. PubMed ID: 8956649 [TBL] [Abstract][Full Text] [Related]
31. T-cell lymphoma/Sézary syndrome in a liver transplant recipient. Al Ajroush N; Rafique Sheikh K; Kadry R; Almutawa A; Alfadley A J Cutan Med Surg; 2012; 16(1):68-71. PubMed ID: 22418000 [TBL] [Abstract][Full Text] [Related]
32. Sézary syndrome: relative increase in T helper lymphocytes demonstrated by monoclonal antibodies. Thivolet J; Fulton R; Souteyrand P; Gaucherand M; Claudy A Acta Derm Venereol; 1982; 62(4):337-40. PubMed ID: 6183869 [No Abstract] [Full Text] [Related]
33. Expression of CD164 on Malignant T cells in Sézary Syndrome. Guenova E; Ignatova D; Chang YT; Contassot E; Mehra T; Saulite I; Navarini AA; Mitev V; Dummer R; Kazakov DV; French LE; Hoetzenecker W; Cozzio A Acta Derm Venereol; 2016 May; 96(4):464-7. PubMed ID: 26524186 [TBL] [Abstract][Full Text] [Related]
34. Progressive outer retinal necrosis syndrome in the course of systemic lupus erythematosus. Turno-Kręcicka A; Tomczyk-Socha M; Zimny A Lupus; 2016 Dec; 25(14):1610-1614. PubMed ID: 27178013 [TBL] [Abstract][Full Text] [Related]
36. Pathogenetic mechanisms of vitiligo in a patient with Sézary syndrome. Knol AC; Quéreux G; Marques-Briand S; Pandolfino MC; Khammari A; Guilloux Y; Dreno B Br J Dermatol; 2005 Dec; 153(6):1207-12. PubMed ID: 16307660 [TBL] [Abstract][Full Text] [Related]
37. Association of change in clinical status and change in the percentage of the CD4+CD26- lymphocyte population in patients with Sézary syndrome. Introcaso CE; Hess SD; Kamoun M; Ubriani R; Gelfand JM; Rook AH J Am Acad Dermatol; 2005 Sep; 53(3):428-34. PubMed ID: 16112348 [TBL] [Abstract][Full Text] [Related]
38. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636 [TBL] [Abstract][Full Text] [Related]
39. Transformation of Sézary syndrome into CD30+ anaplastic large T-cell lymphoma after alemtuzumab therapy with evidence of clonal unity. Nevet MJ; Zuckerman T; Sahar D; Bergman R Am J Dermatopathol; 2015 Jan; 37(1):73-7. PubMed ID: 25548993 [TBL] [Abstract][Full Text] [Related]
40. Bromovinyldeoxyurdine treatment of outer retinal necrosis due to varicella-zoster virus: a case-report. Dullaert H; Maudgal PC; Leys A; Dralands L; Clercq E Bull Soc Belge Ophtalmol; 1996; 262():107-13. PubMed ID: 9339038 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]